FoxM1: a potential drug target for glioma

By Li Yu   Zhang Sicong   Huang Suyun  

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 223-226

Future Medicine

Access to resources Recommend Favorite

Radiation dosimetry of ¹³¹I-chlorotoxin for targeted radiotherapy in glioma-bearing mice

By Shen Sui   Khazaeli M.   Gillespie G.   Alvarez Vernon  

Journal of Neuro-Oncology, Vol. 71, Iss. 2, 2005-01 ,pp. : 113-119

Springer Publishing Company

Access to resources Recommend Favorite

ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma

By Jin Yao   Bin Zhang   Qiang Huang   Liang Chu   Hua Chen   Jun Dong   Dong Wang   Qing Lan  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1369-1376

Springer Publishing Company

Access to resources Recommend Favorite

Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models

By Grossman Rachel   Brastianos Harry   Blakeley Jaishri   Mangraviti Antonella   Lal Bachchu   Zadnik Patti   Hwang Lee   Wicks Robert   Goodwin Rory   Brem Henry   Tyler Betty  

Journal of Neuro-Oncology, Vol. 116, Iss. 1, 2014-01 ,pp. : 59-65

Springer Publishing Company

Access to resources Recommend Favorite

Glucose Oxidase Conjugated with Anti-endothelial Monoclonal Antibodies: in Vitro and in Vivo Studies

By Muzykantov V.R.   Danilov S.M.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 11-15

Informa Healthcare

Access to resources Recommend Favorite